Sitemap...
- Home
- Models & Services
- About
- News
- Cardiovascular Assessment: The Preceding, Contemporary and Prospective Viewpoint
- CorDynamics to Exhibit Proven Cardiovascular Safety and Discovery Solutions at Society of Toxicology Meeting in Salt Lake City
- CorDynamics to Exhibit at 2009 Meeting of the American College of Toxicology
- CorDynamics Garners Travel Award to Safety Pharmacology Society Meeting in September
- CorDynamics to Exhibit at 2009 Safety Pharmacology Society Meeting
- CorDynamics and Elixir Pharmaceuticals Will Present at the Drug Safety Strategies to De-Risk Compounds IBC Life Sciences Conference in August
- CorDynamics Addresses Current Market Conditions with Affordable Cardiovascular Safety and Discovery Solutions
- CorDynamics to Exhibit Affordable Cardiovascular Safety and Discovery Solutions at Society of Toxicology Meeting in Baltimore
- CorDynamics Celebrates Five Years in Business
- CorDynamics Expands Facility to Offer More Telemetry, Anesthetized and Isolated Heart Studies
- Publications
- PM101: A Cyclodextrin-Based Intravenous Formulation of Amiodarone Devoid of Adverse Hemodynamic Effects
- Comparison of the Cardiac Electrophysiology and General Toxicology of Two Formulations of Intravenous Amiodarone in Dogs
- The Hypotensive Effect of Intravenous Amiodarone is Sustained Throughout the Maintenance Infusion Period
- Advantages of the Perfused Isolated Rabbit Heart for the Assessment of the Electrophysiologic and Haemodynamic Effects of Drug Candidates
- Webinars
- Contact Us
